Align Technology (NASDAQ:ALGN – Get Free Report) had its price objective hoisted by stock analysts at UBS Group from $200.00 to $260.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. UBS Group’s price objective suggests a potential downside of 2.52% from […]